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Abstract An active sulfotransferase (ST, residues 558-882) 
domain of the human heparan sulfate N-deacetylaseIN-sulfo- 
transferase (hHSNST) has been identified by aligning the amino 
acid sequence of hHSNST to that of mouse estrogen sulfo- 
transferase (EST). The bacterially expressed ST domain 
transfers the 5'-sulfuryl group of 3'-phosphoadenosine-5'-phos- 
phosuifate (PAPS) to only deacetylated heparin with an 
efficiency similar to that previously reported for the purified 
rat HSNST. Moreover, the Km,PAPS (2.1 pM) of the ST domain 
is also similar to that of the rat enzyme. Lys 4s is a key residue in 
mEST catalysis. The residue corresponding to Lys as is conserved 
in all known beparan sulfate sulfotransferases (Lys °14 in the ST 
domain of hHSNST). Mutation of Lys 614 to Ala abolishes N- 
sulfotransferase activity, indicating an important catalytic role of 
Lys °14 in the ST domain. Crystals of the ST domain have been 
grown (orthorhombic space group P21212) with diffraction to 2.5 
A resolution. 
© 1998 Federation of European Biochemical Societies. 
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I. Introduction 
of 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to various 
endogenous and exogenous ubstrates [10]. There are two ma- 
jor sets of the sulfotransferases: cytosolic and Golgi mem- 
brane enzymes. The membrane enzymes generally sulfate 
higher molecular weight substrates uch as oligosaccharides 
and proteins and exhibit high substrate specificity. On the 
other hand, the cytosolic enzymes uch as estrogen sulfotrans- 
ferase (EST) catalyze the sulfation of low molecular weight 
substrates including steroid hormones, bioamines, pharma- 
ceuticals and environmental chemicals ([10] and the subse- 
quent series). Contrary to the membrane nzymes, these cyto- 
solic enzymes display broad but distinct substrate specificity. 
Recently, the X-ray crystal structure of mouse EST has been 
solved for the sulfotransferase family and has identified po- 
tential catalytic residues [11,12]. Structural and mutational 
studies of a membrane sulfotransferase have not yet been 
reported. 
To characterize the structure and function of the sulfotrans- 
ferase activity of human heparan sulfate N-deacetylase/N-sul- 
fotransferase (hHSNST), we have bacterially expressed the ST 
domain and have performed a site-directed mutagenesis study. 
Moreover, the ST domain has been crystallized. 
Heparan sulfate is a member of the glycosaminoglycans 
that also include chondroitin, keratan and dermatan sulfates. 
Organic sulfates play important roles in various biological 
processes uch as blood coagulation, cell growth, and viral 
infection [1-3]. Biosynthesis of heparan sulfate is catalyzed 
by a group of Golgi membrane nzymes called heparan sulfate 
sulfotransferases including N-deacetylase/N-sulfotransfer- 
ase [1]. Heparan sulfate N-deacetylase/N-sulfotransferase 
(HSNST) is a multifunctional enzyme that catalyzes the se- 
quential reactions of deacetylation and sulfation, converting 
N-acetylated glucosaminoglycan to the N-sulfated product [4]. 
N-Sulfation is obligatory for heparan biosynthesis to proceed 
with subsequent reactions such as 2-O-, 3-0- and 6-O-sulfa- 
tion. Recent progress in the cloning of cDNAs has begun to 
provide the molecular basis for understanding the function of 
these enzymes, as well as the biological and therapeutic im- 
plications of these enzymes [5-9]. 
HSNST is an enzyme within the large sulfotransferase fam- 
ily. Sulfotransferases catalyze transfer of the 5'-sulfuryl group 
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2. Materials and methods 
2.1. cDNA cloning, expression and purification 
Using a GCG program BESTFIT, the amino acid sequence of the 
mouse estrogen sulfotransferase [12] was aligned to that of the human 
heparan sulfate N-deacetylase/N-sulfotransferase [7]. A cDNA encod- 
ing the 325 residues from positions 558 to 882 of the human enzyme 
was then amplified from a cDNA of RCC23 (human renal carcinoma 
cell line) and was verified by the nucleotide sequencing. The amplified 
cDNA was inserted into pGEX-4T3 vector between BamHI and 
EcoRl site and transformed into Eseherichia coli BL21 cell in order 
to express the sulfotransferase domain with the 325 amino acids under 
the conditions previously reported from this laboratory [13]. The ex- 
pressed fusion protein was applied to a glutathione-Sepharose 4B 
(Pharmacia) column (2.6 O× 10 cm) equilibrated with 50 mM Tris- 
HCI (pH 8.3) containing 0.1 M NaC1. The ST domain was eluted by 
cleavage with bovine thrombin solution (Sigma, 10 U/ml in the equi- 
libration buffer) at a flow rate of 0.1 ml/min. The eluate was passed 
through a DEAE Sepharose column (5 ml bed volume), then an 
benzamidine Sepharose (Pharmacia) column (2 ml bed volume) and 
finally applied on a PAPS-agarose (Sigma) column (1.6 •x5  cm). 
The bound protein was eluted with the buffer containing 1 mM 
PAP. The purified protein was analyzed with a 10% SDS-polyacryl- 
amide gel. 
2.2. Site-directed mutagenesis 
We mutated the codon Lys 614 to that of Ala using a QuickChange 
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2.3. SuljotransJerase assay and other analytical methods' 
The N-sulfotransferase activity determination was based on the re- 
ported method [5] using desulfated heparin as substrate. The reaction 
mixture (total volume of 50 p.l) consisting of 50 mM HEPES-NaOH 
(pH 7.0), 0.15 M NaCI, 0.75 mg/ml protamine, 0.1 mg/ml or 0.2 mg/ 
ml desulfated heparin, 10 ng enzymes and :~'sS-PAPS was incubated 
for 10 min at 37°C. The reaction was stopped by immersing for 2 min 
in boiling water. The products were co-precipitated with 20 gg chon- 
droitin sulfate by adding 150 lal ethanol containing 1.3'/, potassium 
acetate. The precipitates were washed with 70% ethanol and dissolved 
in 50 p.l H20 then applied on Mi~zro-spin G25 columns (Pharmacy). 
The radioactivities of the eluates were determined by liquid scintilla- 
tion. KIn.PAPS was determined by the direct linear plot [14]. The en- 
zyme concentrations were determined using a molar absorbance co- 
efficient (e2~ = 60 790) calculated from the content of tryptophan and 
tyrosine in the enzyme. 
2.4. Crystallization and data collection 
The purified bacterially expressed ST domain was dialyzed against 
100 mM Tris-HCl buffer (pH 8.3) containing 100 mM NaC1. The 
resulting solution was then adjusted to a concentration of 18 mg/ml 
and 4 mM PAP (3'-phosphoadenosine-5'-phosphate). Crystals were 
grown in the presence of 200 mM NaCl, 30% PEG3000 and Bis-Tris- 
propane (pH 7.0). The diffraction data were collected at room temper- 
ature on an RAXIS IV area detector system and a Rigaku RV-300 
rotating anode generator. The data were processed using DENZO and 
scalepack l15]. 
3. Results and discussion 
3.1. Sequence identification of the ST  domain 
We have aligned the sequence of 878 amino acids in 
hHSNST with that of mEST. The 294 residue sequence of 
mEST aligns to residues 558-882 of hHSNST (Fig. 1). 
Thus, the sulfotransferase activity of hHSNST appears to be 
restricted to this carboxy-terminal region of 325 residues (now 
designated the ST domain). The ST domain is 42 residues 
shorter from its N-terminus than the putative sulfotransferase 
domain previously defined [16]. Although the ST domain 
shares only 18.6% sequence identity with the mEST, it con- 
tains the conserved sequence motifs for PAPS binding [17]: 
5'PSB (5'-phosphosulfate) and 3'PB (Y-phosphate) (indicated 
by boxes in Fig. 1). In the X-ray crystal structure of the 
ternary EST-PAP-E2 complex, Lys 4s of the 5'PSB moti f  is 
directly coordinated to the 5'-phosphate group of PAP and 
is in a position to function as a catalytic residue [12,17]. In 
addition, Lys 4~ is conserved in all known sulfotransferases 
(aligned to Lys ~14 in the ST domain). Intriguingly, other pos- 
sible catalytic residues (Lys 1°~ and His 1°8) of EST are not 






I METSMP . . . . .  E¥¥EVFGEF RGVL . . . . .  M DKRFTKYWED VEMFLARPDD 40 
558 LQTLPPVQLA QKYFQIFSEE KDPLWQDPCE DKRHKDIWSK -EKTCDRFPK 606 
5 'PSB 
41 LV IAT~P~SG TTW~SEVVYM IYKEGDVEKC KEDAIFNRIP  YLECRN . . . .  86  
607  LL I IO I~GTT- -~YLFLGMHPDLSSN¥ PSSETFEE IQ FFNGHNYHKG 645 
/ 
mEST: 87 . . . .  EDLI . . . .  NGIKQLKE KESPRIVKTH LPPKVLPASF  WEKNCK~IYL  128 
hHSNST: 655 IDWYMEFFPI  PSNTTSDFYF EKSANYFDSE VAPRRAAALL  - -PKAK~TI  702 
3 'PB 
mEST: 129 CRNAKDVAVS Y¥~-  . . . . . . .  FLLMITSYP NPKSFSEFVE KF - -MQGQVP 168 
hHSNST: 703 L INPADRA¥S W~HQRAHDD PVALKYTFHE V IT&GSDASS KLRAL~NRCL 752 
mEST: 169 YGSWYDHVKA WWEKSKNSRV LFMFYEDMKE DIRREVVKL I  EFLERKPSAE 218 
hHSNST: 753 VPGWY&THIE  RWLSAYHANQ ILVLDGKL- -  - LRTEPAKVM DMVQKFLG- -  797 
mEST: 
hHSNST:  
219 LVDRI IQHTS FQEMKNNPST NYTMMPEEMM NQKVSPFMRK - -G I IGDWKN 266 
798 -VTNTIDYHK TLAFDPKKGF WCQLLEGGKT KCLGKSKGRK ¥PEMDLDSRA 846 
mEST: 269  HFPEALRERF DEHYK~MKD C- - -TVKFRM EL 295  
hHSNST:  847  FLKDYYRDHN IELSKLLYKM GQTLPTWLRE DLQNTR 882  
s 
I 558 882 
hHSNST : l N -deacety lase  t~ N-sul  fo t rans ferase  
1 295 
mEST : I I 
Fig. 1. Amino acid sequence alignment and ST domain. A: The alignment of EST with hHSNST was produced using the GCG BESTFIT pro- 
gram. Numbers indicate the residue positions in each enzyme. The 5'-phosphosulfate binding motif (5'PSB) and 3'-phosphate binding motif 
(3'PB) are boxed. Lys Gt4 is shadowed. B: A possible domain structure of hHSNST is depicted. Arrows indicate the regions from which oligonu- 
cleotide primers were generated for PCR amplification. 






- 47 .5K  
- 32.5K  
213 
5'PSB 
mEST 47 PKSGTTWI 
hHSNST 613 QKTGTTAL 
haHS2OST 82 PKTASTSF 
hHS3OST 63 RKGGTRAL 
hHS6OST 85 QKTGGTTF 
Fig. 3. Multiple sequence alignments of heparan sulfate sulfotrans- 
ferases. This alignment was made by extending our previous work 
using Multiple [17]. The amino acid sequences used here: mouse es- 
trogen sulfotransferase (mEST, $78182), human heparan sulfate N- 
deacetylase/N-sulfotranseferase (hHSNST, U18918), hamster hepar- 
an sulfate 2-O-sulfotramsferase (hHS2OST, D88811), human hepar- 
an sulfate 3-O-sulfotransferase (haHS3OST, AF019386) and human 
heparan sulfate 6-O-sulfotransferase (hHS6OST, AB006179). The 
numbers in parentheses indicate their accession numbers in the 
NCBI/GenBank protein sequence database, whereas those in the fig- 
ure show the positions of the first residues of the sequences. The 
Lys ~s and its corresponding lysines are in bold. 5'PSB represents 
the sequence motif that binds to the 5'-phosphosulfate of PAPS 
[12,16,20]. 
Fig. 2. SDS-gel electrophoresis of the wild-type ST domain and 
K641A mutant. 5 pg of protein and protein molecule weight 
markers (NEB) were electrophoresed on a 10% SDS polyacrylamide 
gel. The gel was then stained by Coomassie blue. 
3.2. Characterization of the ST domain 
The ST domain was successfully expressed in BL21 cells 
transformed by the pGEX vector containing the amplified 
cDNA that encodes the 325 residues of the domain. Approx- 
imately 15 mg of the pure domain protein can be obtained 
from a 1 1 bacterial culture. An apparent molecular weight of 
the bacterially expressed ST domain is 38 kDa, in agreement 
with the 37861 Da calculated from the amino acid sequence 
(Fig. 2). The ST domain displays a high heparan sulfotrans- 
ferase activity of 231 nmol sulfate incorporated/min/mg pro- 
tein (Table 1). After correcting for the substrate concentra- 
tion, the specific activity of the ST domain is comparable to 
the activity previously reported for purified rat HSNST [18]: 
As expected, the ST domain does not sulfate N-acetylated 
substrates. The low sulfotransferase activity of the ST domain 
toward O-desulfated/N-sulfated substrate may be due to an 
incomplete N-sulfation of this substrate. Alternatively, the 
ST domain may have broadened its substrate specificity with 
sulfating the 2-, 3- and/or 6-positions. This is unlikely, how- 
ever, since the ST domain has exhibited no sulfation activity 
toward NDSNAc in that the 3-0-, 2-0- and/or 6-O-positions 
are partially desulfated (Table 1). KI,.PAPS of the ST domain is 
similar to that of rat HSNST (1 ~tM) [19] and also to the 
corresponding K,, values of heparan sulfate 2-O-sulfotransfer- 
ase and heparan sulfate 6-O-sulfotransferase [5,6]. The bacte- 
Table 1 
Sulfotransferase activity of the ST domain and mutant enzymes 
rially expressed ST domain thus appears to have retained the 
original enzymatic properties for the hHSNST. 
The potential catalytic residue Lys Is of EST is conserved in 
all known sulfotransferases including heparin sulfate sulfo- 
transferases. Previous site-directed mutagenesis studies have 
shown that mutation of the conserved Lys residues (Lys ts in 
EST; Lys :'9 in flavonol sulfotransferase) licits a profound 
effect on transferase activity [20,21]. To examine whether the 
Lys~S-corresponding Lys G]a of the ST domain is also critical 
for the N-sulfotransferase activity, this Lys residue was mu- 
tated to Ala (K614A mutant) and expressed in BL21 cells, 
The purified mutant enzyme exhibits the same apparent mo- 
lecular weight on a SDS-polyacrylamide g l electrophoresis a
the wild-type ST domain (Fig. 2). Most importantly, the mu- 
tated enzyme shows no detectable heparan sulfotransferase 
activity (Table 1), indicating that Lys ~H plays a key role in 
conferring heparan N-sulfotransferase activity to hHSNST. 
3.3. OTstallization of the ST domain 
Since our bacterially expressed ST domain is an active t n- 
zyme, its X-ray crystal structure may provide useful informa- 
tion for understanding substrate specificity and catalytic 
mechanism of hHSNST. Crystals of the ST domain were 
grown to 0.05 × 0.05 × 0.2 mm in the presence of the inactive 
cofactor PAP. These crystals are suitable for X-ray crystallo- 
graphic analysis and diffract to 2.5 A resolution. The space 
group and unit cell dimensions have been determined (Table 
2). There is one molecule in the asymmetric unit giving a V,, 
of 2.2 A:~/Da, that corresponded to a solvent content of 44% 
[22]. We have collected a nearly complete set of native data 
and are now searching for heavy metal derivatives. 
Enzyme Substrate 
ADS CDSNAc CDSNS NDSNAc 
Wild-type 231 +_ 14 II _+7 57_+8 n.d. 
K641A u.d. n.d. n.d. n.d. 
The activity was measured as described in Section 2 and is expressed as p_mole of sulfate/min/mg protein. ADS represents completely desulfated 
heparin at all positions; CDSNAc completely desulfated (the 2-, 3-, 6-positions)/N-acetylated heparin; CDSNS completely desulfated (the 2-, 3-, 
and 6-positions)/N-sulfated heparin NDSNAc N-desulfated/N-acetylated heparin in that the 2-, 3- and 6-positions are partially sulfated, n.d., 
activity not detectable. 
214 T. Sueyoshi et al./FEBS Letters 433 (1998) 211-214 
Table 2 
Crystallographic data 
Space group P2~ 2~2 
Unit cell parameters (A) a = 89.2 
b=55.4 
c=66.3 
# of crystals° 1 
Resolution (A) 2.5 
% Completeness 98 
3.4. General discussion 
PAPS is the ubiquitous ulfate donor of all known mam- 
malian sulfotransferases, regardless of whether membrane or 
cytosolic enzymes. The recently solved EST-PAP-E2 structure 
has revealed PAPS binding motifs and the key residues that 
interact with the 5'- and Y-phosphate groups, respectively 
[12]. The 5'PSB motif of mEST consists of the carboxy-termi- 
hal five residues of the PSB loop and the first two residues of 
the following helix 3 [17]. The PSB loop resembles the P-loop 
structure motif often conserved as a nucleotide binding site in 
many kinases and phosphatases [23]. Our previous multiple 
sequence alignment of the cytosolic and membrane sulfotrans- 
ferases has provided sequence vidence that these motifs are 
also conserved in the membrane ST enzymes including 
hHSNST [17]. In fact, the catalytic residue Lys 4s of EST is 
conserved in the heparan sulfate 2-O-, 3-0- and 6-O-sulfo- 
transferases (Lys s3, Lys 64 and Lys s6, respectively), in addition 
to Lys 6i4 of the N-sulfotransferase (Fig. 3). The present find- 
ing (no detectable sulfotransferase activity in the K614A mu- 
tant) has now shown that the 5'PSB motif and this lysine 
residue are functionally conserved in hHSNST, as well as in 
the other heparan sulfate sulfotransferases. 
Until very recently the lack of sequence similarity between 
cytosolic and membrane sulfotransferases was enigmatic, since 
they catalyze the same sulfuryl transfer eaction using PAPS 
as the donor. In addition to the previous equence motif anal- 
ysis and structural correlation based on the EST crystal [18], 
the present mutational analysis of Lys G11 has revealed struc- 
tural and functional similarities of the PAPS binding site in all 
sulfotransferases. It has appeared that the sulfotransferase 
family enzymes conserve the structure and function of the 
PAPS binding site, in spite of their immensely diverse sub- 
strate specificities. The determination of the X-ray crystal 
structure of the ST domain of hHSNST and its comparison 
to the EST structure may provide clues for understanding the 
structural basis for the substrate specificity of the sulfotrans- 
ferase family. 
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